A new study using induced pluripotent stem cell (iPSC) technology links astrocyte dysfunction to Parkinson’s disease (PD) pathology. The study highlights the role of brain astrocyte cells in PD pathology and the potential of iPSC-derived cells in disease modelling and drug discovery.